Tapewire

Nasdaq · USD

IART

INTEGRA LIFESCIENCES HOLDINGS CORP

Export transactions ↓
Tapewire entity
2707
SEC CIK
0000917520
Parsed reports
472

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 10, 2023 Filed Mar 14, 2023 20:20 UTC
De Witte JanDirector · President & CEO
GrantRestricted Stock Units · Derivative 26,008 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018446 · doc4.xml · derivative · entry 3

De Witte Jan · CIK 0001776929 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,033

Underlying: Common Stock · 26,008 shares

Expires not disclosed

F2 · derivative.exercise_price: The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/10/2023 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

F2 · derivative.exercise_date: The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/10/2023 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

F2 · derivative.expiration_date: The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/10/2023 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:20 UTC
De Witte JanDirector · President & CEO
GrantNon-Qualified Stock Option (right to buy) · Derivative 63,717 $0.00 Strike: $52.87 $0.00
Disclosure

SEC source: 0001209191-23-018446 · doc4.xml · derivative · entry 2

De Witte Jan · CIK 0001776929 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,717

Underlying: Common Stock · 63,717 shares

Expires 2031-03-10

F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:21 UTC
DAVIS ROBERT T. JR.EVP & President, TT
GrantNon-Qualified Stock Option (right to buy) · Derivative 10,354 $0.00 Strike: $52.87 $0.00
Disclosure

SEC source: 0001209191-23-018451 · doc4.xml · derivative · entry 9

DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,354

Underlying: Common Stock · 10,354 shares

Expires 2031-03-10

F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:21 UTC
DAVIS ROBERT T. JR.EVP & President, TT
GrantCommon Stock 4,227 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018451 · doc4.xml · nonDerivative · entry 1

DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,147

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:18 UTC
Singh HarvinderExec VP & PRES, International
GrantRestricted Stock Units · Derivative 3,670 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018441 · doc4.xml · derivative · entry 2

Singh Harvinder · CIK 0001949782 · Exec VP & PRES, International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,635

Underlying: Common Stock · 3,670 shares

Expires not disclosed

F2 · derivative.exercise_price: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023.

F2 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023.

F2 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:18 UTC
Singh HarvinderExec VP & PRES, International
GrantNon-Qualified Stock Option (right to buy) · Derivative 8,990 $0.00 Strike: $52.87 $0.00
Disclosure

SEC source: 0001209191-23-018441 · doc4.xml · derivative · entry 1

Singh Harvinder · CIK 0001949782 · Exec VP & PRES, International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,990

Underlying: Common Stock · 8,990 shares

Expires 2031-03-10

F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:16 UTC
Schwartz EricEVP, Chief Legal Officer & Sec
GrantNon-Qualified Stock Option (right to buy) · Derivative 12,419 $0.00 Strike: $52.87 $0.00
Disclosure

SEC source: 0001209191-23-018435 · doc4.xml · derivative · entry 9

Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,419

Underlying: Common Stock · 12,419 shares

Expires 2031-03-10

F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:16 UTC
Schwartz EricEVP, Chief Legal Officer & Sec
GrantCommon Stock 5,070 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018435 · doc4.xml · nonDerivative · entry 1

Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,222

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:14 UTC
Mosebrook JeffreySVP, Fin, PFO & PAO
GrantCommon Stock 1,256 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 2

Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,177

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:14 UTC
Mosebrook JeffreySVP, Fin, PFO & PAO
GrantCommon Stock 1,832 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 1

Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,921

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:14 UTC
Evoli LisaEVP & CHRO
GrantNon-Qualified Stock Option (right to buy) · Derivative 6,201 $0.00 Strike: $52.87 $0.00
Disclosure

SEC source: 0001209191-23-018420 · doc4.xml · derivative · entry 9

Evoli Lisa · CIK 0001661715 · EVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,201

Underlying: Common Stock · 6,201 shares

Expires 2031-03-10

F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:14 UTC
Evoli LisaEVP & CHRO
GrantCommon Stock 2,532 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018420 · doc4.xml · nonDerivative · entry 1

Evoli Lisa · CIK 0001661715 · EVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,137

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:13 UTC
McBreen Michael J.EVP & President, CSS
GrantNon-Qualified Stock option (right to buy) · Derivative 19,912 $0.00 Strike: $52.87 $0.00
Disclosure

SEC source: 0001209191-23-018416 · doc4.xml · derivative · entry 10

McBreen Michael J. · CIK 0001814943 · EVP & President, CSS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,912

Underlying: Common Stock · 19,912 shares

Expires 2031-03-10

F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:13 UTC
McBreen Michael J.EVP & President, CSS
GrantCommon Stock 8,128 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 2

McBreen Michael J. · CIK 0001814943 · EVP & President, CSS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,382

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:13 UTC
McBreen Michael J.EVP & President, CSS
GrantCommon Stock 9,458 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 1

McBreen Michael J. · CIK 0001814943 · EVP & President, CSS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,254

Read SEC document
March 07, 2023 Filed Mar 8, 2023 21:17 UTC
McBreen Michael J.EVP & President, CSS
SaleCommon Stock 1,843 $54.29 $100,064.39
Disclosure

SEC source: 0001209191-23-017194 · doc4.xml · nonDerivative · entry 1

McBreen Michael J. · CIK 0001814943 · EVP & President, CSS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,796

F1 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $54.2931 to $54.3001. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 21:58 UTC
McBreen Michael J.EVP & President, CSS
Tax withholdingCommon Stock 723 $55.09 $39,830.07
Disclosure

SEC source: 0001209191-23-016360 · doc4.xml · nonDerivative · entry 1

McBreen Michael J. · CIK 0001814943 · EVP & President, CSS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,639

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:20 UTC
DAVIS ROBERT T. JR.EVP & President, TT
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,566 $0.00 Strike: $26.87 $0.00
Disclosure

SEC source: 0001209191-23-015775 · doc4.xml · derivative · entry 3

DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,566 shares

Expires 2023-03-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 03/23/2015.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:20 UTC
DAVIS ROBERT T. JR.EVP & President, TT
SaleCommon Stock 1,566 $55.21 $86,463.09
Disclosure

SEC source: 0001209191-23-015775 · doc4.xml · nonDerivative · entry 2

DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,920

F1 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $55.2118 to $55.22. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:20 UTC
DAVIS ROBERT T. JR.EVP & President, TT
Exercise / conversionCommon Stock 1,566 $26.87 $42,070.59
Disclosure

SEC source: 0001209191-23-015775 · doc4.xml · nonDerivative · entry 1

DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,486

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2023 Filed Feb 28, 2023 21:29 UTC
Evoli LisaEVP & CHRO
SaleCommon Stock 3,767 $57.00 $214,730.68
Disclosure

SEC source: 0001209191-23-013669 · doc4.xml · nonDerivative · entry 1

Evoli Lisa · CIK 0001661715 · EVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,605

F1 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $57 to $57.08. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:35 UTC
De Witte JanDirector · President & CEO
GrantCommon Stock 8,848 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009758 · doc4.xml · nonDerivative · entry 1

De Witte Jan · CIK 0001776929 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,848

F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:30 UTC
Schwartz EricEVP, Chief Legal Officer & Sec
GrantCommon Stock 5,641 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 4

Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,152

F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:30 UTC
Schwartz EricEVP, Chief Legal Officer & Sec
GrantCommon Stock 1,400 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 3

Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,511

F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:30 UTC
Schwartz EricEVP, Chief Legal Officer & Sec
GrantCommon Stock 560 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 2

Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,111

F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:30 UTC
Schwartz EricEVP, Chief Legal Officer & Sec
GrantCommon Stock 2,156 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 1

Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,551

F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:25 UTC
DAVIS ROBERT T. JR.EVP & President, TT
GrantCommon Stock 1,883 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 4

DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,920

F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:25 UTC
DAVIS ROBERT T. JR.EVP & President, TT
GrantCommon Stock 1,779 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 3

DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,037

F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:25 UTC
DAVIS ROBERT T. JR.EVP & President, TT
GrantCommon Stock 1,067 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 2

DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,258

F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:25 UTC
DAVIS ROBERT T. JR.EVP & President, TT
GrantCommon Stock 2,379 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 1

DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,191

F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:18 UTC
McBreen Michael J.EVP & President, CSS
GrantCommon Stock 1,919 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 4

McBreen Michael J. · CIK 0001814943 · EVP & President, CSS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,362

F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:18 UTC
McBreen Michael J.EVP & President, CSS
GrantCommon Stock 1,680 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 3

McBreen Michael J. · CIK 0001814943 · EVP & President, CSS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,443

F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:18 UTC
McBreen Michael J.EVP & President, CSS
GrantCommon Stock 1,008 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 2

McBreen Michael J. · CIK 0001814943 · EVP & President, CSS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,763

F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:18 UTC
McBreen Michael J.EVP & President, CSS
GrantCommon Stock 1,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 1

McBreen Michael J. · CIK 0001814943 · EVP & President, CSS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,755

F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:14 UTC
Mosebrook JeffreySVP, Fin, PFO & PAO
GrantCommon Stock 411 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 4

Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,089

F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:14 UTC
Mosebrook JeffreySVP, Fin, PFO & PAO
GrantCommon Stock 385 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 3

Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,678

F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:14 UTC
Mosebrook JeffreySVP, Fin, PFO & PAO
GrantCommon Stock 231 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 2

Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,293

F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:14 UTC
Mosebrook JeffreySVP, Fin, PFO & PAO
GrantCommon Stock 510 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 1

Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,062

F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:07 UTC
Evoli LisaEVP & CHRO
GrantCommon Stock 1,137 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009704 · doc4.xml · nonDerivative · entry 4

Evoli Lisa · CIK 0001661715 · EVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,372

F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:07 UTC
Evoli LisaEVP & CHRO
GrantCommon Stock 1,054 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009704 · doc4.xml · nonDerivative · entry 3

Evoli Lisa · CIK 0001661715 · EVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,235

F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:07 UTC
Evoli LisaEVP & CHRO
GrantCommon Stock 632 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009704 · doc4.xml · nonDerivative · entry 2

Evoli Lisa · CIK 0001661715 · EVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,181

F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:07 UTC
Evoli LisaEVP & CHRO
GrantCommon Stock 1,552 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009704 · doc4.xml · nonDerivative · entry 1

Evoli Lisa · CIK 0001661715 · EVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,549

F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date.

Read SEC document
January 18, 2023 Filed Jan 19, 2023 21:17 UTC
De Witte JanDirector · President & CEO
Exercise / conversionRestricted Stock Units · Derivative 431 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-004012 · doc4.xml · derivative · entry 3

De Witte Jan · CIK 0001776929 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,025

Underlying: Common Stock · 431 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the first installment vested on 1/18/2023 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.

F1 · derivative.exercise_date: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the first installment vested on 1/18/2023 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.

F1 · derivative.expiration_date: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the first installment vested on 1/18/2023 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.

Read SEC document
January 18, 2023 Filed Jan 19, 2023 21:17 UTC
De Witte JanDirector · President & CEO
Tax withholdingCommon Stock 431 $54.78 $23,610.18
Disclosure

SEC source: 0001209191-23-004012 · doc4.xml · nonDerivative · entry 2

De Witte Jan · CIK 0001776929 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
January 18, 2023 Filed Jan 19, 2023 21:17 UTC
De Witte JanDirector · President & CEO
Exercise / conversionCommon Stock 431 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-004012 · doc4.xml · nonDerivative · entry 1

De Witte Jan · CIK 0001776929 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 431

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 08, 2022 Filed Dec 8, 2022 22:09 UTC
Mosebrook JeffreySVP, Fin & Princ Acct Officer
SaleCommon Stock 279 $56.22 $15,684.32
Disclosure

SEC source: 0001209191-22-060378 · doc4.xml · nonDerivative · entry 1

Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,552

Read SEC document
November 01, 2022 Filed Nov 3, 2022 20:10 UTC
De Witte JanDirector · President & CEO
GrantRestricted Stock Units · Derivative 29,441 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-055496 · doc4.xml · derivative · entry 1

De Witte Jan · CIK 0001776929 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,456

Underlying: Common Stock · 29,441 shares

Expires not disclosed

F1 · derivative.exercise_price: The award was a restricted stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 11/1/2022 and which shall be delivered to Mr. De Witte within 30 days of the vesting of each installment. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 11/1/2022 and which shall be delivered to Mr. De Witte within 30 days of the vesting of each installment. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 11/1/2022 and which shall be delivered to Mr. De Witte within 30 days of the vesting of each installment. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

Read SEC document
October 31, 2022 Filed Jan 31, 2023 21:11 UTC
ESSIG STUARTDirector
GiftCommon Stock 159,012 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-005679 · doc5.xml · nonDerivative · entry 1

ESSIG STUART · CIK 0001187574 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By GRAT III

Disclosed balance after: 0

F1 · balance_after: In accordance with the provisions of the Grantor Annuity Trust, 159,012 shares of the Issuer's common stock were transferred from the GRAT to the Stuart M. Essig 2010 Remainder Trust upon termination of the GRAT.

Read SEC document
October 12, 2022 Filed Oct 13, 2022 20:16 UTC
Singh HarvinderExec VP & PRES, International
GrantRestricted Stock Units · Derivative 11,965 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-053568 · doc4.xml · derivative · entry 1

Singh Harvinder · CIK 0001949782 · Exec VP & PRES, International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,965

Underlying: Common Stock · 11,965 shares

Expires not disclosed

F1 · derivative.exercise_price: The award was a restricted stock unit award which will vest 100% on the third anniversary of the grant date of 10/12/2022

F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 100% on the third anniversary of the grant date of 10/12/2022

F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 100% on the third anniversary of the grant date of 10/12/2022

Read SEC document
August 10, 2022 Filed Aug 11, 2022 20:19 UTC
Evoli LisaExecutive Vice President &CHRO
SaleCommon Stock 1,165 $55.81 $65,019.58
Disclosure

SEC source: 0001209191-22-045420 · doc4.xml · nonDerivative · entry 1

Evoli Lisa · CIK 0001661715 · Executive Vice President &CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,997

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.